Back

Socioeconomic disparities in guideline directed medical therapy for HFrEF: a population-based cohort study using electronic health records (the Netherlands)

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Digitoxin and other therapeutic strategic advances Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Ms Jorna van Eijk

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Effects of glucagon like peptide 1 receptor agonist initiation in patients with heart failure and reduced ejection fraction and implantable cardiac devices
Doctor P. Marques (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Real-world burden of heart failure with reduced ejection fraction and dapagliflozin use at 2 years after approval in 9 countries from Central Eastern Europe and Baltic Area: EVOLUTION-HF CEE-BA study
Professor I. Gruev (Sofia, BG)
Abstract Slides Video
Presentation thumbnail
Hemoglobin, hematocrit and heart failure: the SGLT2 inhibitor connection
Doctor D. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of early initiation of mineralocorticoid receptor antagonists in patients with worsening heart failure: a meta-analysis of randomized controlled trials
Doctor R. Laborante (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Digitoxin and other therapeutic strategic advances

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Impact of social, educational and ethnic determinants in guideline-directed medical therapy implementation during heart failure hospitalization
thumbnail
Congress Presentation
Socioeconomic factors and SGLT2 inhibitor prescription in heart failure a retrospective analysis using real-world data
thumbnail
Congress Presentation
Effect of improving utilization of guideline-directed medical therapy for heart failure.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources